Litigation Details for STATE OF NEW YORK v. CEPHALON, INC. (E.D. Pa. 2016)
✉ Email this page to a colleague
STATE OF NEW YORK v. CEPHALON, INC. (E.D. Pa. 2016)
| Docket | ⤷ Try a Trial | Date Filed | 2016-08-04 |
| Court | District Court, E.D. Pennsylvania | Date Terminated | 2017-07-25 |
| Cause | 15:1 Antitrust Litigation | Assigned To | Mitchell S. Goldberg |
| Jury Demand | None | Referred To | |
| Patents | RE37,516 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in STATE OF NEW YORK v. CEPHALON, INC.
The small molecule drugs covered by the patent cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for STATE OF NEW YORK v. CEPHALON, INC. (E.D. Pa. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-08-04 | 1 | Complaint | United States Patent No. 5,618,845, subsequently re-issued in 2002 as U.S. Patent No. RE37,516 (Collectively…misrepresentation to the Patent & Trademark Office ("PTO"). Despite knowing that the patent was invalid… publishes the claimed patents - without any independent review of the patents - in its "Approved…generic drug; (II) the listed patents have expired; (III) the listed patents will expire before the generic…04/16 Page 18 of 39 (1) patent expiration, (2) resolution of the patent litigation in favor of the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
